What is Ace & Tate?
Founded in 2013, Ace & Tate has redefined the prescription eyeglasses industry by integrating high-quality design with an accessible, tech-enabled retail model. Headquartered in the Netherlands, the company operates at the intersection of fashion and healthcare, utilizing a vertically integrated supply chain to bypass traditional markups. Its market position is characterized by a strong emphasis on sustainability and customer-centric digital experiences, which have allowed it to capture significant market share from legacy optical providers. The company's ability to maintain a cohesive brand identity while scaling across European markets highlights its sophisticated approach to modern retail logistics and consumer engagement.
How much funding has Ace & Tate raised?
Ace & Tate has raised a total of $16.1M across 1 funding round:
Other Financing Round
$16.1M
Other Financing Round (2020): $16.1M with participation from Rinkelberg Capital
Key Investors in Ace & Tate
Rinkelberg Capital
A private investment firm focused on long-term capital appreciation and strategic support for growth-stage enterprises.
What's next for Ace & Tate?
With the recent injection of capital, Ace & Tate is well-positioned to accelerate its enterprise-level growth initiatives. Strategic priorities likely include the expansion of its omnichannel presence, further investment in proprietary diagnostic technology, and the optimization of its supply chain to support broader international distribution. As the company transitions into its next phase of maturity, the focus will shift toward deepening its competitive moat through enhanced personalization and sustainable manufacturing practices. This financing serves as a critical catalyst for long-term value creation, enabling the firm to navigate the complexities of the global eyewear market while maintaining its commitment to design-led innovation and operational excellence.
See full Ace & Tate company page
